Free tool
Oncology stocks
We cover 3 companies grouped under the Oncology theme. The median market value in the group is $2.12B. Across the group, the median move over the past trading day is −3.26%. Price change over the past year runs from −1.8% to +288.1% across the middle 80 percent of the group, with a median of +76.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
3 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| 0I3Q.L | Corcept Therapeutics Incorporated | $122.59 | −2.12% | +233.46% | +75.99% |
| HCM.L | HUTCHMED (China) Limited | 178.00 GBP | +0.85% | −12.75% | −21.24% |
| NANO.PA | Nanobiotix S.A. | 34.14 EUR | +3.96% | +79.68% | +341.09% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.